{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:10:22Z","timestamp":1779253822121,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002797","name":"Government of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003850","name":"Inner Mongolia University","doi-asserted-by":"publisher","award":["10000-21311201\/092"],"award-info":[{"award-number":["10000-21311201\/092"]}],"id":[{"id":"10.13039\/501100003850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jinorgbio.2026.113322","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:52:33Z","timestamp":1775145153000},"page":"113322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Glycosylated ancillary ligand bearing Pt(II) anticancer complexes: In vitro and in vivo anticancer evaluation and EMT inhibition in triple-negative breast cancer"],"prefix":"10.1016","volume":"280","author":[{"given":"Zerui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Jamil","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fufu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shad","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minglu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiz-Ur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2026.113322_bb0005","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0020","first-page":"1864","article-title":"Breast cancer molecular subtypes: from TNBC to QNBC","volume":"6","author":"Hon","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0025","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038508","article-title":"HER2\/PI3K\/AKT pathway in HER2-positive breast cancer: a review","volume":"103","author":"Pan","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108775","article-title":"MRPL55 promotes BC progression as a prognostic biomarker by modulating lipogenesis and cyclin-dependent kinase pathways, from multi-omics to drug repurposing","volume":"120","author":"Khan","year":"2026","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.681476","article-title":"Current triple-negative breast cancer subtypes: dissecting the most aggressive form of breast cancer","volume":"11","author":"Ensenyat-Mendez","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70410","article-title":"Advances in the understanding of the pathogenesis of triple-negative breast cancer","volume":"13","author":"Liu","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0045","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jcb.24709","article-title":"Apoptosis regulation at the mitochondrial outer membrane","volume":"115","author":"Gillies","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0050","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.18632\/oncotarget.2792","article-title":"Bcl-2 family proteins in breast development and cancer: could mcl-1 targeting overcome therapeutic resistance?","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0055","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.18632\/oncotarget.28031","article-title":"Interactions of multidomain pro-apoptotic and anti-apoptotic proteins in cancer cell death","volume":"12","author":"Chota","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3268136","article-title":"Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits","volume":"2021","author":"Sharifi-Rad","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0065","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0070","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1021\/acs.jmedchem.4c01699","article-title":"In vitro and in vivo anticancer activities of water-soluble Ru(II)(\u03b76-p-cymene) complexes via activating apoptosis central regulators and possibilities of new antitumor strategies in triple negative breast cancers","volume":"68","author":"Man","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0075","article-title":"FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC","volume":"2024","author":"Khan","year":"1868","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.05.023","article-title":"Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort","volume":"189","author":"Grinda","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17020228","article-title":"Triple-negative breast cancer progression and drug resistance in the context of epithelial-mesenchymal transition","volume":"17","author":"B\u0142aszczak","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0090","article-title":"The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0095","doi-asserted-by":"crossref","first-page":"15966","DOI":"10.18632\/oncotarget.3862","article-title":"Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194985","article-title":"Vimentin is at the heart of epithelial mesenchymal transition (EMT) mediated metastasis","volume":"13","author":"Usman","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn7571","article-title":"Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin","volume":"14","author":"Grasset","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117894","article-title":"Advancements in platinum-based anticancer drug development: a comprehensive review of strategies, discoveries, and future perspectives","volume":"112","author":"Sahoo","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0115","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0120","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0125","doi-asserted-by":"crossref","first-page":"10835","DOI":"10.1039\/D2DT01875F","article-title":"A chemical perspective on the clinical use of platinum-based anticancer drugs","volume":"51","author":"Alassadi","year":"2022","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0130","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jconrel.2025.02.006","article-title":"Drug delivery for platinum therapeutics","volume":"380","author":"Liu","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0135","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27082466","article-title":"Application of approved cisplatin derivatives in combination therapy against different cancer diseases","volume":"27","author":"Tsvetkova","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ica.2018.11.039","article-title":"Synthesis, crystal structure and cytotoxicity assays of a copper(II) nitrate complex with a tridentate ONO acylhydrazone ligand. Spectroscopic and theoretical studies of the complex and its ligand","volume":"487","author":"Burgos-Lopez","year":"2019","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0150","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.1039\/C8NJ06274A","article-title":"Cu(ii) and zn(ii) complexes with a poly-functional ligand derived from o-vanillin and thiophene. Crystal structure, physicochemical properties, theoretical studies and cytotoxicity assays against human breast cancer cells","volume":"43","author":"Rodr\u00edguez","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0155","article-title":"Quantitative proteomics analysis of triple-negative breast cancers","volume":"9","author":"Mariano","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104438","article-title":"Metabolic vulnerabilities in cancer: a new therapeutic strategy","volume":"201","author":"El-Tanani","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0170","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/acs.jmedchem.4c02717","article-title":"Recent progress in the development of glucose transporter (GLUT) inhibitors","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0175","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/CCO.0b013e328356da72","article-title":"Glucose transporters in cancer metabolism","volume":"24","author":"Adekola","year":"2012","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trecan.2018.11.003","article-title":"Gluconeogenesis in cancer: function and regulation of PEPCK, FBPase, and G6Pase","volume":"5","author":"Wang","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0185","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0729-3","article-title":"Mannose impairs tumour growth and enhances chemotherapy","volume":"563","author":"Gonzalez","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0190","first-page":"2957","article-title":"Mannose shows antitumour properties against lung cancer via inhibiting proliferation, promoting cisplatin-mediated apoptosis and reducing metastasis","volume":"22","author":"Wang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12672-021-00447-0","article-title":"Mannose enhances the radio-sensitivity of esophageal squamous cell carcinoma with low MPI expression by suppressing glycolysis","volume":"13","author":"Luo","year":"2022","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.226","article-title":"Mannose synergizes with chemoradiotherapy to cure cancer via metabolically targeting HIF-1 in a novel triple-negative glioblastoma mouse model","volume":"10","author":"Liu","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0205","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1111\/cas.15138","article-title":"Mannose and phosphomannose isomerase regulate energy metabolism under glucose starvation in leukemia","volume":"112","author":"Saito","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0210","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1038\/s41467-023-39711-y","article-title":"Establishing mammalian GLUT kinetics and lipid composition influences in a reconstituted-liposome system","volume":"14","author":"Suades","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.126622","article-title":"Ancillary ligand modulation effect on crystallization, metal aquation, fluorescence, lipophilicity, electrochemistry and anticancer activities of Pt(II) complexes","volume":"417","author":"Zou","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0220","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ejmech.2018.12.052","article-title":"ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway","volume":"164","author":"Rahman","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117522","article-title":"Elucidating the dual mechanistic action and synergism of platinum complexes bearing valproic acid as leaving ligand on NF-\u03baB and inflammatory pathways in glioma","volume":"290","author":"Man","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113920","article-title":"Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: ascribe possibilities of new antitumor strategies","volume":"227","author":"Bai","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0235","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1158\/0008-5472.CAN-14-0247","article-title":"Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes","volume":"74","author":"Hall","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0240","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s13058-014-0415-9","article-title":"A joint analysis of metabolomics and genetics of breast cancer","volume":"16","author":"Tang","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0245","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/s41416-022-01869-5","article-title":"Recent insights into the effects of metabolism on breast cancer cell dormancy","volume":"127","author":"Bartlome","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0250","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbrc.2017.04.004","article-title":"Mannose-conjugated platinum complexes reveals effective tumor targeting mediated by glucose transporter 1","volume":"487","author":"Liu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0255","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2016.09.047","article-title":"Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents","volume":"125","author":"Gao","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0260","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1038\/s41467-021-23737-1","article-title":"Glucose-oxidase like catalytic mechanism of noble metal nanozymes","volume":"12","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0265","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11033-023-08920-5","article-title":"Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review","volume":"51","author":"Yayan","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.877543","article-title":"Mannose: a sweet option in the treatment of cancer and inflammation","volume":"13","author":"Nan","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.jinorgbio.2026.113322_bb0275","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1021\/acs.jproteome.4c00998","article-title":"Mannose-6-phosphate isomerase functional status shapes a rearrangement in the proteome and degradome of mannose-treated melanoma cells","volume":"23","author":"de Vasconcellos Racorti","year":"2024","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102236","article-title":"Platinum glycoconjugates: \u201csweet bullets\u201d for targeted cancer therapy?","volume":"72","author":"Vaidya","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0285","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1021\/acsomega.3c06922","article-title":"Synthesis and biological evaluation of a novel sugar-conjugated platinum(II) complex having a tumor-targeting effect","volume":"9","author":"Omokawa","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174363","article-title":"Apoptosis deregulation and the development of cancer multi-drug resistance","volume":"13","author":"Neophytou","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0295","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc776","article-title":"Death and anti-death: tumour resistance to apoptosis","volume":"2","author":"Igney","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0305","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1016\/j.matpr.2022.07.098","article-title":"Recent advances and application of ruthenium complexes in tumor malignancy","volume":"72","author":"Kanaoujiya","year":"2023","journal-title":"Mater. Today Proc."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0310","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1016\/j.bbamcr.2013.04.014","article-title":"Induction of mitochondrial biogenesis protects against caspase-dependent and caspase-independent apoptosis in l6 myoblasts","volume":"1833","author":"Dam","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0315","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1002\/jcp.25797","article-title":"Epithelial-mesenchymal transition (EMT): a biological process in the development, stem cell differentiation, and tumorigenesis","volume":"232","author":"Chen","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10555-008-9169-0","article-title":"EMT, the cytoskeleton, and cancer cell invasion","volume":"28","author":"Yilmaz","year":"2009","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0325","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20211754","article-title":"Epithelial\u2013mesenchymal transition and its transcription factors","volume":"42","author":"Debnath","year":"2022","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0330","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-016-0502-x","article-title":"Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications","volume":"15","author":"Serrano-Gomez","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jinorgbio.2026.113322_bb0335","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.carres.2012.09.025","article-title":"Revisit of the phenol o-glycosylation with glycosyl imidates, BF\u2083\u00b7OEt\u2082 is a better catalyst than TMSOTf","volume":"363","author":"Li","year":"2012","journal-title":"Carbohydr. Res."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016201342600111X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016201342600111X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:43:05Z","timestamp":1779252185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016201342600111X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":67,"alternative-id":["S016201342600111X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113322","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycosylated ancillary ligand bearing Pt(II) anticancer complexes: In vitro and in vivo anticancer evaluation and EMT inhibition in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113322"}}